Literature DB >> 16514658

Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor.

Jung Sub Lee1, Jong Seo Lee, Hyoung Lok Roh, Chul Hong Kim, Jin Sup Jung, Kuen Tak Suh.   

Abstract

It has been suggested that decreased replication capacity of mesenchymal stem cells (MSCs) or decreased MSCs activity in the bone marrow is related to nontraumatic osteonecrosis (ON). However, little is known about differentiation ability of MSCs according to the risk factor of nontraumatic ON. We hypothesize that differentiation abnormalities in MSCs of the bone marrow of the proximal femurs might be related to nontraumatic ON of the femoral head. The purpose of this study was to investigate the osteogenic and adipogenic differentiation ability of MSCs in patients with nontraumatic ON of the femoral head. We examined the differentiation ability of MSCs in cultures derived from the bone marrow of the proximal femurs obtained from 10 patients with hip osteoarthritis (OA) and 37 patients with nontraumatic ON of the femoral head undergoing hip replacement surgery. We analyzed the osteogenic and adipogenic differentiation ability of MSCs according to the risk factor [alcohol-induced (15 patients), idiopathic (12 patients) and steroid-induced (10 patients)] of nontraumatic ON of the femoral head separately and compared it with patients with hip OA. The osteogenic activity was measured as the extracellular matrix calcification by alizarin red S staining and the alkaline phosphatase activity, and the adipogenic activity was measured as the accumulation of Oil red O-positive lipid vacuoles. The osteogenic differentiation ability of MSCs in patients with alcohol-induced and idiopathic ON was significantly reduced compared with that in patients with OA (p < 0.05 and p < 0.05, respectively). In patients with steroid-induced ON, the osteogenic differentiation ability was found to be increased, but the difference was not statistically significant. The adipogenic differentiation ability of MSCs was not significantly changed in patients with alcohol-induced, idiopathic, and steroid-induced ON compared to patients with OA. Our results indicate that altered osteogenic differentiation ability in MSCs is related to nontraumatic ON of the femoral head and the differentiation potential of MSCs in patients with nontraumatic ON differs according to its risk factor. Copyright 2006 Orthopaedic Research Society

Entities:  

Mesh:

Year:  2006        PMID: 16514658     DOI: 10.1002/jor.20078

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  44 in total

1.  Osteogenic abilities of bone marrow stromal cells are not defective in patients with osteonecrosis.

Authors:  Jeong Joon Yoo; Won Seok Song; Kyung-Hoi Koo; Kang Sup Yoon; Hee Joong Kim
Journal:  Int Orthop       Date:  2008-02-19       Impact factor: 3.075

2.  Collagen type V a2 (COL5A2) is decreased in steroid-induced necrosis of the femoral head.

Authors:  Fan Yang; Pengbo Luo; Hao Ding; Changqing Zhang; Zhenhong Zhu
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  Long Noncoding RNA FAM83H-AS1 Modulates SpA-Inhibited Osteogenic Differentiation in Human Bone Mesenchymal Stem Cells.

Authors:  Haojie Wu; Faqi Cao; Wu Zhou; Gang Wang; Guohui Liu; Tian Xia; Mengfei Liu; Bobin Mi; Yi Liu
Journal:  Mol Cell Biol       Date:  2020-02-12       Impact factor: 4.272

4.  Global urinary metabolic profiling of the osteonecrosis of the femoral head based on UPLC-QTOF/MS.

Authors:  Gang Yang; Gang Zhao; Jian Zhang; Sichuan Gao; Tingmei Chen; Shijia Ding; Yun Zhu
Journal:  Metabolomics       Date:  2019-02-20       Impact factor: 4.290

Review 5.  Cytotherapy of osteonecrosis of the femoral head: a mini review.

Authors:  You-Shui Gao; Chang-Qing Zhang
Journal:  Int Orthop       Date:  2010-04-02       Impact factor: 3.075

6.  Nitric oxide content and apoptosis rate in steroid-induced avascular necrosis of the femoral head.

Authors:  Rui Bai; Wanlin Liu; Aiqing Zhao; Zhengqun Zhao; Dianming Jiang
Journal:  Exp Ther Med       Date:  2015-05-26       Impact factor: 2.447

7.  Adipose-derived Mesenchymal Stem Cells Are Phenotypically Superior for Regeneration in the Setting of Osteonecrosis of the Femoral Head.

Authors:  Cody C Wyles; Matthew T Houdek; Ruben J Crespo-Diaz; German A Norambuena; Paul G Stalboerger; Andre Terzic; Atta Behfar; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2015-06-13       Impact factor: 4.176

8.  Protective effects and mechanism of Panax Notoginseng saponins on oxidative stress-induced damage and apoptosis of rabbit bone marrow stromal cells.

Authors:  Hui Qiang; Chen Zhang; Zhi-bin Shi; Hua-qing Yang; Kun-zheng Wang
Journal:  Chin J Integr Med       Date:  2010-11-26       Impact factor: 1.978

Review 9.  Stem Cell Therapy for Osteonecrosis of the Femoral Head: Current Trends and Comprehensive Review.

Authors:  Lei Zhao; Alan David Kaye; Aaron J Kaye; Alaa Abd-Elsayed
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

10.  Lithium prevents rat steroid-related osteonecrosis of the femoral head by β-catenin activation.

Authors:  Zefeng Yu; Lihong Fan; Jia Li; Zhaogang Ge; Xiaoqian Dang; Kunzheng Wang
Journal:  Endocrine       Date:  2015-10-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.